ImmuCell Corporation Accrued Income Taxes, Current
ImmuCell Corporation (ICCC) had Accrued Income Taxes, Current of $54.56 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2026-08-13
- 2026-06-30: Accrued Income Taxes, Current $54.56K.
- 2026-03-31: Accrued Income Taxes, Current $8.61K.
- 2025-12-31: Accrued Income Taxes, Current $6.69K.
- 2025-09-30: Accrued Income Taxes, Current $3.87K.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2026-06-30 | $54.56K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $8.61K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $6.69K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $3.87K 10-Q · filed 2025-11-13 |
| 2024-12-31 | $5.82K 10-K · filed 2026-03-30 |
| 2024-09-30 | $1.17K 10-Q · filed 2024-11-13 |
| 2024-03-31 | $4.39K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $3.05K 10-K · filed 2025-03-28 |
| 2023-09-30 | $964.00 10-Q · filed 2023-11-13 |
| 2023-06-30 | $735.00 10-Q · filed 2023-08-10 |
| 2022-12-31 | $4.89K 10-K · filed 2024-04-01 |
| 2022-09-30 | $3.73K 10-Q · filed 2022-11-21 |
| 2021-12-31 | $2.14K 10-K · filed 2023-03-29 |
| 2021-09-30 | $994.00 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |